Ultra Chip Inc
TPEX:3141
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Ultra Chip Inc
TPEX:3141
|
TW |
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
US |
|
A
|
Aptiv PLC
F:D7A
|
IE |
|
K
|
Kinross Gold Corp
SWB:KIN2
|
CA |
|
Daito Trust Construction Co Ltd
OTC:DIFTY
|
JP |
|
R
|
Redcare Pharmacy NV
DUS:RDC
|
NL |
|
A
|
Aurubis AG
F:NDA
|
DE |
|
Spire Inc
NYSE:SR
|
US |
|
Netstreit Corp
F:64N
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Ultra Chip Inc's stock price target?
Not Available
Ultra Chip Inc does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Ultra Chip Inc?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is -3%.
What is the Gross Profit forecast for Ultra Chip Inc?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 12 years is -3%.
What is the Operating Income forecast for Ultra Chip Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been -9%. The projected CAGR for the next 12 years is 12%.
What is the Net Income forecast for Ultra Chip Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 8 years is 12%.